Check how many companies work on your scientific topic(s) among 50,000+ industry professionals in 10,000+ companies worldwide.
We are in direct collaboration with companies’ R&D, External Innovation, BD&L and Investment teams
Present your innovation to relevant industry experts and receive their direct feedback.
Bring your technologies to the forefront of Inospin’s 50,000 industry experts, get valuable insights on your technologies and generate new collaboration opportunities
Check how many companies work on your scientific topic(s) among 50,000+ industry professionals in 10,000+ companies worldwide.
We are in direct collaboration with companies’ R&D, External Innovation, BD&L and Investment teams
Submit your innovation and our team will check if it matches active partnering programs!
We reach out to these industry experts and ask for their feedback on your technology.
Receive access to a private and dedicated platform to connect with the interested ones.
More than 100,000 exchanges and feedback
Department Head, auto-immune diseases
Company size: 5,001+
The approach is interesting. However, no information had been generated on the effect of this target in in vivo models of disease, especially in dermatological disease. It is then still too early to understand the role of the target in psoriasis. For this reason, the potential of this target for the development of an alternative treatment in psoriasis is difficult to foresee.
Feedback: Interested with more data
Director of external innovation
Company size: 1,001-5,000
Compared to other potential targets, the credentialing of this target in immuno-inflammation is still limited in our view, particularly also regarding genetic evidence. We think that it is better to focus on other approaches for the moment.
Feedback: Not market potential
Director of R&D, Oncology
Company size: 1,001-5,000
Given the broad expression of the target we are a bit sceptical regarding the possible covalent binding mode of the compound. In addition, it would be helpful to have more data regarding selectivity of the compound e.g. in a CEREP screen, eADME data etc. to truly assess the potential.
Feedback: Interested with more data
Manager, Drug discovery planning & management
Company size: 10,001+
There are not so many publications regarding the role of this target in autoimmune diseases. However, there are a few intriguing reports connecting the target to RA, and particularly COPD. We would like to connect with the experts to discuss further.
Feedback: Want to take a meeting
Director Cardiometabolic Diseases Research
Company size: 10,001+
We are not interested in this pathway, as it has been extensively studied in the last years. Indeed, it has been proven that this is not an efficient approach for the treatment of NASH.
Feedback: Not innovative enough
Vice President Formulation & Delivery
Company size: 1,001-5,000
We are actively looking for novel delivery methods for large molecules to the eye. We are thinking that your system could be applied to some of our compounds. We would like to discuss with you based on your experience if it is feasible and how we could collaborate.
Feedback: Want to take a meeting
Head of Delivery Technologies
Company size: 10,001+
We are strongly interested in delivery systems in ophthalmology and especially with sustained siRNA release capability. I would like to take a meeting with you to discuss further.
Feedback: Want to take a meeting
Director External Innovation
Company size: 10,001+
There are unfortunately no in vivo examples of delivery of oligonucleotides to the posterior eye segment in the proposal. Furthermore, in order to correctly assess the potential of the technologies related to sustained release, over 6 months of results are needed. Please come back to us with these data.
Feedback: Interested with more data
Senior Scientist
Company size: 5,001-10,000
This is a risky approach for a differentiated therapy in psoriasis, as CNS safety issues can be expected.
Feedback: Not market potential
Global Technology Scouting Manager
Company size: 10,001+
The approach is interesting. However, this pathway has been extensively studied and it is already targeted with very efficient antibodies. Furthermore, other targets can also achieve the same MoA.
Feedback: Not innovative enough
Head of material innovation
Company size: 10,001+
It is broad and long-time but seems interesting for what can be understood by the description. How can the microresonators be interrogated in a non-invasive manner? Would this method need a pre-characterization for each tyre specification taken into consideration? Viscoelastic response is heavily impacted by external variables (e.g. Temperature, Pavement surface, etc). How would you consider them?
Feedback: Interested with more data
VP external innovation
Company size: 5,001-10,000
The proposed methodology would be quite advantageous if it can really be applied in tire property sensing. We are curious to know more about the status of development of real-time manufacturing quality control methods and devices based on the above measurement approach. We quite like the non-invasive nature of this approach during the assessment.
Feedback: Want to take a meeting
R&D director
Company size: 10,001+
While it appears to be still quite at a basic development level, the novelty of the concept is quite interesting to us especially on rapid probe-based characterization methods for viscoelastic surfaces. We would like to take a meeting to discuss with the project leader for a potential collaboration.
Feedback: Want to take a meeting
Business Development Manager
Company size: 1,001-5,000
FEA approaches can be used during the tyre development phase to forecast, given a mission profile, tyre life. They are massively heavy from a calculation point of view. External variables cannot be taken into account precisely. This is unfortunately out of our current main scope for the challenge we have.
Feedback: Not market potential
Research Scientist, AI center
Company size: 10,001+
This FEM approach for estimating tire tread groove depth has previously been examined extensively in our team, and our conclusion was that the heavy load of necessary calculation would prevent on-board applications. Therefore, at this time, we are not interested in this.
Feedback: Not market potential
Principal Scientist
Company size: 1,001-5,000
The proposed algorithm works based on Finite Elements Method (FEM), which may be of interest to our strategy. Using FEM, contact area and contact pressure distribution between the tire and the ground base could be calculated. We would be interested in more modeling details if available for further discussion.
Feedback: Interested with more data
Senior Scientist - AI department
Company size: 1,001-5,000
We are very much interested in getting in touch with the project leaders on this technology. It appears to have unique advantages in their wear modeling approach, although we would like to discuss further with a NDA to examine if it can be aligned with our company’s technology.
Feedback: Want to take a meeting
R&D Director
Company size: 1,001-5,000
The proposal of a tribological wear model is of our interest. Which kind of input data would you need to feed the tribological model? How would you gather or measure them? Which kind of sensor would be suitable for the approach?
Feedback: Interested with more data
External innovation Director
Company size: 1,001-5,000
Looks interesting. Tribological approaches are complex and it would need many input data. We would ask clarifications on this point. Could this be applicable to a wide range of tyre formulations?
Feedback: Interested with more data
Senior scientist
Company size: 10,001+
In fact, we have looked at a similar binder composition in the past and concluded the manufacturing process would be too complicated for us.
Feedback: Not market potential
Scientist, Fermentation department
Company size: 10,001+
The proposed approach of designing a fermenter appears to be applicable and indeed we would like to discuss further with the researcher on the current status.
Feedback: Want to take a meeting
Senior Business Development Manager
Company size: 5,001-10,000
I am interested in knowing the competitive advantage or uniqueness of this extract compared with commercially available antimicrobial compounds in the food & beverage industry. I would like to take a meeting to have more information.
Feedback: Want to take a meeting
R&D Director
Company size: 1,001-5,000
We are interested in using cactus, but this approach is hard to use at an industrial scale, and can not be commercialized.
Feedback: Not market potential
Senior Business Development Manager
Company size: 1,001-5,000
We are interested in medicinal plants. However, we need more data regarding their benefit on health. Indeed, we cannot judge usefulness with the given data.
Feedback: Interested with more data
R&D project leader - Beverages
Company size: 5,001-10,000
We would be interested to know if the taste of the proposed plant-based milk is similar as cow milk
Feedback: Interested with more data
Senior Scientist
Company size: 1,001-5,000
The fermentation technology is quite interesting. However, we would be interested in knowing application examples for the food & beverages industry, as well as the benefit of the technique.
Feedback: Interested with more data
Open Innovation Director
Company size: 10,001+
We cannot find any uniqueness as there are various products containing minerals and amino acids
Feedback: Not innovative enough
VP Innovation
Company size: 5,001-10,000
We are interested in Medieterranean diet, but we cannot find any uniqueness, because fruits and vegetables are common materials.
Feedback: Not innovative enough
Business Development Manager
Company size: 10,001+
We are interested in reusing agricultural waste. However, there are various existing useful polyphenols and we cannot find further novelty.
Feedback: Not innovative enough
R&D senior project leader
Company size: 10,001+
We liked the fact that the technique presented in the proposal for wood liquefaction is relatively simple and appears to be applicable in many facilities without much infrastructure investment. However, we need to know how much molecular fragmentation can be achieved during this process, because our main interest is for small bio-derived building block molecules.
Feedback: Interested with more data
Business Development Director
Company size: 5,001-10,000
We are absolutely looking for industry-relevant new polymerization techniques, and this approach may have a potential in the long run. However, unfortunately, it seems the technique was demonstrated in a small number of systems in academic research, and we would need to wait and see if this can be generally applied to a much wider selection of polymer systems for various applications such as coatings, semiconductor films, etc.
Feedback: Not market potential
R&D Director
Company size: 10,001+
This new approach of combined redox photoactivated polymerization appears quite interesting to us, although the TRL seems still low at this stage. We can certainly speak with the leader in this project to see what are the next steps forward in their research group so that we can examine if there are any R&D interests of our research team that may possibly be aligned.
Feedback: Want to take a meeting
Senior Scientist
Company size: 1,001-5,000
The technology presented in the proposal uses the addition of metal components in the system. They also conduct metal-free research in another study. Is this technology not possible to cure the shielding part we recruited this time? We would be interested in discussion with more data provided on this aspect.
Feedback: Interested with more data
Open Innovation Leader
Company size: 5,001-10,000
We are interested in having a first discussion with the project leader, especially to discuss his expertise in surface chemistry.
Feedback: Want to take a meeting
R&D Project Manager - Biobased Products
Company size: 5,001-10,000
The patent is too old. Unfortunately, we don’t see any potential market for this technology.
Feedback: Not market potential
Business Development Manager
Company size: 1,001-5,000
There is no advantage against other existing coating technologies. In addition, there is no protection of intellectual property.
Feedback: Not market potential
Project leader - Methodologies for tyre development
Company size: 10,001+
The technology is interesting. However, this strategy would imply a complex hardware to be fitted on the vehicle. It would make industrialization difficult.
Feedback: Not market potential
VP innovation
Company size: 1,001-5,000
The stage of the work is too early in my eyes and would be a too long term investment into a still unproven approach. However, I would be interested to review the technology in some time, with additional data.
Feedback: Interested with more data
R&D Leader
Company size: 5,001-10,000
We would be interested in this proposal if it would he be possible to design particles of a specific size and with given physical chemical properties.
Feedback: Interested with more data
Inospin (formerly known as Biowebspin) is the #1 partnering network for Scientific Innovations in Pharma & Biotech, Veterinary, Crop Science & Agriculture, Food & Beverages, Medtech, Consumer Care & Cosmetics, Chemistry, Material Sciences, IT and Engineering.
For industry, Inospin is the platform to detect innovative research projects and academic collaboration opportunities among 2.5 million researchers worldwide in 30,000 universities, research institutes and start-ups.
For academic researchers & start-ups, Inospin is the platform to find industrial partners among more than 50,000 industry professionals in innovation driven companies with active external R&D programs.
By connecting top academic researchers & start-ups and innovation-driven industry professionals from all around the world, Inospin has become the central partnering Hub of R&D Excellence to stay ahead of scientific innovations
Inospin pays a lot of attention to the privacy, intellectual property, confidentiality and security of its member data.
Inospin is a matchmaking platform between academia & industry. Inospin is not involved in the IP discussion and is not charging any success or license fees.
Your «Open Innovation» opportunities on Inospin are only visible by industrial partners and the Inospin team. You can remove your data at any time. Inospin strongly recommends that you do not enter any confidential data or if you do so, that your technology transfer office agrees the submission of your pre-proposal on Inospin. If you directly submit your pre-proposal on an industrial partner website, you will agree their terms, conditions and privacy policy of our industrial partner website. Inospin is not responsible for the content, accuracy, or opinion of its industrial partner website.
As a Swiss International company, Inospin has high standard security and privacy system. Inospin is in accordance with the Federal Data Protection and Information Commissioner.
Check here the terms and conditions of the matchmaking service of Inospin.
Check here the terms and the privacy policy of Inospin website